Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20042
20052
20064
20073
20084
20094
20103
20115
20127
20137
20145
20156
20161
20174
20181
20193
20201
20221
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Terminated10
Unknown status5
Active, not recruiting5
Recruiting4
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer8
Novartis Pharmaceuticals6
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)4
Incyte Corporation4
Gilead Sciences3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
APT Pharmaceuticals, Inc.2
Assistance Publique - Hôpitaux de Paris2
AstraZeneca2
Foundation for Liver Research2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome76
Pain9
Lymphoma, Follicular8
Psoriasis7
Constipation6
Leukemia6
Hepatitis C5
Migraine Disorders5
Pruritus5
Headache4

Trials

Showing 26 to 50 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.